Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Overview of attention for article published in Journal of Hematology & Oncology, October 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

patent: 39 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 203 Dimensions

Readers on

mendeley: 148 Mendeley
citeulike: 1 CiteULike

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 39 patents that reference this research output.

Treatment of cancer with TOR kinase inhibitors

Grant US-11166950-B2

United States of America

Treatment of hepatocellular carcinoma characterized by hepatitis B virus infection

Grant US-11096940-B2

United States of America

Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy

Application US-10391092-B2

United States of America

Treatment of cancer with dihydropyrazino-pyrazines

Application US-10183019-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 35 additional patents.